'Evidence lacking' for mental health monitoring tech

The Lampard Inquiry is exploring the utilization of Oxevision technology in mental health wards across the NHS, which has been employed in over 2,000 patient cases over a 24-year span. Despite Oxevision claiming its technology has significantly aided staff in responding to safety incidents, recent findings suggest a lack of robust, independent evidence supporting its effectiveness.

Experts from the University of Oxford, who reviewed 45 studies used to justify the technology's implementation, concluded that these studies did not provide strong evidence of improved patient safety, acceptability, or cost-effectiveness. Oxevision's spokesperson acknowledged the difficulty in conducting ideal studies in mental health ward settings.

Law firm Hodge Jones & Allen, representing bereaved families, emphasized the absence of clear evidence to demonstrate Oxevision's benefits. Campaign group Stop Oxevision has been advocating for its discontinuation, citing concerns about unregulated technology lacking robust evidence. The inquiry will reconvene in October to decide on interim recommendations, with the final report anticipated in 2028.

The Essex Partnership University NHS Foundation Trust acknowledged the need for ongoing improvements in patient care, with the inquiry's recommendations playing a vital role.